JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(6):265-268

Optimization of the extraction method for the determination of methadone and its metabolite EDDP in urine by gas chromatography

R. Horáková*, J. Valentová, I. Pechová, F. Devínsky
Univerzita Komenského Bratislava, Farmaceutická fakulta, Katedra chemickej teórie liečiv

The present study aimed to develop a suitable extraction method for the determination of methadone and it's metabolite EDDP in human urine by gas chromatography with a nitrogen-phosphorus detector (NPD). The extraction method was optimized in an effort to receive the most satisfactory yield of the mentioned compounds from human urine. The highest yields were obtained by alkaline extraction (~ pH 9) with dietylether. Proadiphene (PA) was used as the internal standard. The most efficient yields were determined as follows: 91 ± 5 % for methadone (MTD) and 86 ± 5 % for its metabolite EDDP. The detection limit (LOD) of MTD was 8 ng/ml, for EDDP 23 ng/ml, and the limit of quantification (LOQ) was 27 ng/ml of MTD and for EDDP 77 ng/ml. The accuracy of this method inter day was found for MTD 1.1-2.32 %, for EDDP 7.3-9.3 % and intra day for MTD it was 9.1-13.7 %, for EDDP 4.7-8.7 %. The suitability of the developed method was checked for routine monitoring of MTD and it's metabolite EDDP in human urine for 5 different samples taken from methadone maintenance program.

Keywords: methadone (MTD); 2-ethylidene-3,3-diphenyl-1,5-dimethylpyrrolidine (EDDP); urine; GC, NPD
Grants and funding:

Táto práca bola riešená za podpory grantov VEGA č. 1/3416/06, 1/4300/07 a grantu APVV č. 20-030804.

Received: September 25, 2008; Accepted: October 29, 2008; Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáková R, Valentová J, Pechová I, Devínsky F. Optimization of the extraction method for the determination of methadone and its metabolite EDDP in urine by gas chromatography. Čes. slov. farm. 2008;57(6):265-268.
Download citation

References

  1. Pothier, J., Galand, N.: J. Chromatogr. A, 2005; 1080, 186-191. Go to original source... Go to PubMed...
  2. Whelan, G., Lintzeris, N., McDonough, M. et al.: Methadone guidelines prescribers and pharmacists. 1. vydanie. Melbourne: State of Victoria, 2000; 7-15.
  3. Kreek, M. J., Ann, N. Y.: Acad. Sci., 2000; 909, 186. Go to original source... Go to PubMed...
  4. Eap, CH. B., Buclin, T., Bacmann, P.: Clin. Pharmacokinet., 2002; 41, 1153-1193. Go to original source... Go to PubMed...
  5. Habrdová, V., Balíková, M.: Chem. Listy, 2002; 96, 1006-1009.
  6. Misztal, G.: Acta Pol. Pharm., 1990; 47(5-6), 5-8.
  7. Digiusto, E., Seres, V., Bibb, Z. A., Batey, R.: Addict. Behav., 1996; 21, 319-329. Go to original source... Go to PubMed...
  8. Adams, P. S., Haines-Nutt, R. F.: J. Chromatogr., 1985; 329, 438-440. Go to original source... Go to PubMed...
  9. Pierce, T. L., Murray, A. G. W., Hoff, W.: Science, 1992; 30, 443-447. Go to original source... Go to PubMed...
  10. Choo, R. E., Murphy, C. M., Jones, H. E., Huestis, M. A.: J. Chromatogr. B, 2005; 814, 369-373. Go to original source... Go to PubMed...
  11. Quintela, O., López, P., Bermejo, A.M., López-Rivadulla, M.: J. Chromatogr. B, 2006; 834, 188-194. Go to original source... Go to PubMed...
  12. Müller, K.: Pharmazie, 1983; 38, 596-601. Go to original source... Go to PubMed...
  13. Georgakopoulos, C. G., Kiburis, J. C.: Anal. Chem., 1991; 63, 2021-2004. Go to original source... Go to PubMed...
  14. Schmidt, N., Still, R., Brune, K., Geisslinger, G.: Pharm. Research, 1993; 10 (3), 441-444. Go to original source... Go to PubMed...
  15. Charotti, M., Marsili, R.: J. Microcol., 1994; 6, 577-580. Go to original source...
  16. Balíková, M.: Remedia 1995; 5, 211-216. Go to original source... Go to PubMed...
  17. Cooper, G. A. A., Oliver, J. S.: J. Anal. Toxicol., 1998; 22, 389-392. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.